Pfizer forecasts 2024 revenue below Wall Street expectations

Pfizer forecasts 2024 revenue below Wall Street expectations

The U.S. drugmaker expects its annual revenue to be in the range of $58.5 billion to $61.5 billion compared with analysts’ average estimate of $63.17 billion. Sales of Paxlovid and the vaccine Pfizer makes with German partner BioNTech had boosted revenue over the last two years, helping it generate more than $100 billion in 2022.